Cytokinetics heart drug succeeds in mid-stage study, boosting shares

An experimental drug being developed by South San Francisco-based biotech Cytokinetics improved cardiac function in a mid-stage clinical trial of several dozen patients with a type of heart disease, the company said Monday.